Health Economics & Payer Evidence Lead- Early Assets Solid Tumours

At AstraZeneca every one of our employees makes a difference to patient lives every day. Each and every one of us believes that science has the ability to change lives and that to deliver this takes many people with many skill sets. When we deliver a life-changing medicine, that success comes from the combined efforts of all of our people.

We’re currently looking for a Health Economics & Payer Evidence Lead (HEPEL) to join our Oncology Market Access and Pricing (OMAP) team, supporting our growing early solid tumour oncology pipeline. The global OMAP team are an experienced team of specialists with many different skills, aligned to a common objective –we shape the payer environment; create and deliver highly valued market access solutions to unlock the potential of our life changing medicines for patients. This is accomplished by working with R&D, global commercial, local markets, and external partners and experts to ensure that credible and timely evidence and insights are available at every stage of the development and commercialisation process.

You will lead the development of payer evidence strategies, applications of health economics methods and approaches and engagement with experts. This role requires an in-depth knowledge of global HTA and reimbursement requirements (including JCA), payer evidence (e.g., eg ability to input into clinical trial design and analyses, comparative effectiveness/indirect comparisons), and its strategic application to pharmaceutical development, subsequent market access, and pricing. You are expected to lead these activities for early solid tumour assets including business development working in close alignment with key markets and regions; this will generally focus on initial clinical development plans and for investment decisions for trials with regulatory intent. 

What you'll do

• Develop detailed strategic and tactical planning of payer evidence (e.g., clinical trial design and analysis, economic modelling, evidence synthesis including indirect treatment comparisons) to support market access and reimbursement for assigned projects.

• Ensure that the Payer Evidence Strategy & Plan (PESP) is developed and/or validated at each investment decision with key internal and external stakeholders, that it meets the needs of key markets, EU JCA and respective payer archetypes, aligned with the clinical, medical, and brand strategies, and endorsed by all relevant governance bodies.

• Secure cross-functional input to the PESP including real world evidence (RWE) and patient reported outcomes (PROs) for payer needs.

• Plan budgets effectively and secure resources to deliver the evidence required for patient access as outlined in the PESP.

• Deliver assigned projects to time, budget, and quality, including the management of vendors as required.

• Provide payer relevant evidence requirements into the product development plan, including TPP, Phase 3, RWE/observational studies, integrated evidence plan, and post-launch data planning (anticipating key payer requirements) ensuring its implementation/delivery and communication.

• Drive the brand, policy & publication strategies to support payer needs Prepare requests for proposals for outsourced health economics / payer evidence projects and manage the vendor selection process.

Essential for the role

• Bachelor’s degree in relevant area, such as health economics or a related quantitative discipline.

• 5 years of market access experience

• Oncology therapy area experience.

• Local or global market access launch experience, having worked at a senior level within a health economic consultancy or several years in a pharmaceutical company (either at a marketing company/local affiliate or global level).

• Effective communication skills to different audiences, including both scientific and commercial.

• Influencing, business acumen, and effective prioritisation skills

• Ability to work both collaboratively and independently, understand and apply different technical approaches, and have a wide understanding of different HTA systems.

Desirable for the role

• Master’s degree or higher education in a relevant area.

• Global market access launch experience and global payer evidence development experience.

• Substantial therapy area experience for the role.

• Can demonstrate an in depth and practical understanding of innovative study methodologies, including analyses, that incorporates clinical, medical, regulatory, commercial, payer and HTA needs.

Office Working Requirements